ClinPharm Consulting Forms Strategic Partnership with NCE Biotech
Research Triangle Park, N.C.
Early phase drug development consulting firm ClinPharm Consulting and 20-year pharmaceutical industry veteran Eric Nelson, Ph.D. have announced a partnership to expand upon their offerings for emerging pharmaceutical and biotechnology companies.
Dr. Nelson's firm, NCE Biotech, and ClinPharm Consulting will collaborate to offer an integrated suite of clinical pharmacology, R&D strategy, and business development services, enabling the firms to provide strategic advice related to optimizing drug development programs. This new service enables clients to build the best efficacy/safety and market profiles for their drug development programs for discussions with pharmaceutical company partners and potential investors.
ClinPharm Consulting offers a full clinical pharmacology development package to clients and is a complete resource for virtual companies seeking to advance early phase drug development programs. According to Dr. Banks, early phase drug development needs to be coordinated with business development activities in order to most effectively translate early discussions with potential pharma partners into workable R&D development plans.
NCE Biotech's services include consulting to large pharmaceutical companies to help them divest drug programs; finding Asian investor funding for U.S. biotechnology companies and universities; working with private equity groups to acquire idle biotech assets; and running virtual drug development teams.
"The new partnership with ClinPharm Consulting is a great fit for our firm as the combined team can now provide cost-effective, integrated drug development and business development advice to our clients", said Dr. Nelson, managing partner at NCE Biotech.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
